FDA Inspection 1030893 — Hou Jian, MD

Hou Jian, MD — FEI 3013642523

The FDA completed an inspection of Hou Jian, MD on Oct 26, 2017 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 26, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Shanghai (China)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.